These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27362390)

  • 21. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
    Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
    Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.
    Blecher GE; Stiell IG; Rowe BH; Lang E; Brison RJ; Perry JJ; Clement CM; Borgundvaag B; Langhan T; Magee K; Stenstrom R; Birnie D; Wells GA
    CJEM; 2012 May; 14(3):169-77. PubMed ID: 22575297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous propafenone for conversion of atrial fibrillation in the emergency room].
    Antonelli D; Freedberg NA; Feldman A; Darawsha A; Rosenfeld T
    Harefuah; 2004 Jul; 143(7):471-4, 552, 551. PubMed ID: 15669418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C; Sunderji R; Gin K
    Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone].
    Peciuliene I; Lukoseviciūte A
    Medicina (Kaunas); 2002; 38(12):1212-6. PubMed ID: 12552163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioversion of acute atrial fibrillation in the emergency department: a prospective randomised trial.
    Bellone A; Etteri M; Vettorello M; Bonetti C; Clerici D; Gini G; Maino C; Mariani M; Natalizi A; Nessi I; Rampoldi A; Colombo L
    Emerg Med J; 2012 Mar; 29(3):188-91. PubMed ID: 21422032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of success in the conversion of new-onset atrial fibrillation using oral propafenone.
    Ergene U; Ergene O; Cete Y; Fowler J; Nazli C; Oktay C
    Eur J Emerg Med; 1998 Dec; 5(4):425-8. PubMed ID: 9919447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioversion of recent-onset atrial fibrillation using intravenous antiarrhythmics: A European perspective.
    Lévy S
    J Cardiovasc Electrophysiol; 2021 Dec; 32(12):3259-3269. PubMed ID: 34662471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with acute atrial fibrillation in the ED.
    Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
    Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
    Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
    Bellandi F; Dabizzi RP; Mugnaioni G; Cantini F; Palchetti R
    G Ital Cardiol; 1997 Oct; 27(10):1029-35. PubMed ID: 9410773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation.
    Amit G; Rosen A; Wagshal AB; Bonneh DY; Liss T; Grosbard A; Ilia R; Katz A
    Am J Cardiol; 2004 Jun; 93(12):1558-60. PubMed ID: 15194037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management.
    Dankner R; Shahar A; Novikov I; Agmon U; Ziv A; Hod H
    Cardiology; 2009; 112(4):270-8. PubMed ID: 18815445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment.
    Cristoni L; Tampieri A; Mucci F; Iannone P; Venturi A; Cavazza M; Lenzi T
    Emerg Med J; 2011 Nov; 28(11):932-7. PubMed ID: 20947916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
    Bash LD; Buono JL; Davies GM; Martin A; Fahrbach K; Phatak H; Avetisyan R; Mwamburi M
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):167-79. PubMed ID: 22418856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation.
    Dogan A; Akcay S; Karabacak M; Turker Y; Ozaydin M; Erdogan D
    Int J Clin Pract; 2009 Jul; 63(7):1017-23. PubMed ID: 19570119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.